Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salsola kali, commonly known as Russian thistle or tumbleweed, is a major source of highly allergenic pollen in arid and semi-arid regions worldwide. The immune response to these allergens is a classic Type I hypersensitivity reaction mediated by allergen-specific IgE antibodies. The primary molecular targets within this response are the specific proteins found in the pollen, most notably Sal k 1 (a pectin methylesterase), which is recognized by the majority of sensitized individuals (Barderas et al., 2004, PMID: 15125714). Other significant allergens include Sal k 2 (a kinase-related protein) and Sal k 3 (cobalamin-independent methionine synthase) (WHO/IUIS Allergen Nomenclature). Upon inhalation, these allergens cross-link IgE on mast cells and basophils, triggering the release of inflammatory mediators that cause allergic rhinitis, conjunctivitis, and bronchial asthma. While symptomatic treatments like antihistamines and corticosteroids manage the downstream effects of the immune response, allergen-specific immunotherapy (AIT) using Salsola kali extracts remains the only disease-modifying approach aimed at inducing long-term immune tolerance (Assarehzadegan et al., 2009, PMID: 19364562).
Allergen-specific immunotherapy (AIT) involves the administration of standardized Salsola kali extracts to induce immunological tolerance. This is achieved by shifting the T-cell response from a Th2-dominated allergic profile to a Th1 and regulatory T-cell (Treg) profile, alongside the production of IgG4 blocking antibodies that prevent IgE-mediated mast cell degranulation (Gadermaier et al., 2014, PMID: 24601633).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salsola kali pollen allergens (Sal k allergens).